1887

Abstract

Human immunodeficiency virus (HIV)-positive women have high rates of cervical squamous intraepithelial lesions (SIL) and concurrent human papillomavirus (HPV) infections with a variety of genotypes whose oncogenic risk is poorly documented. The prevalence and persistence of HPV genotypes and HPV16 variants were analysed in 112 HIV-positive and 115 HIV-negative Italian women. HIV-positive women were more likely than HIV-negative women to be infected by HPV at the initial examination (39.3 vs 13.9 %, <0.001) and to have a higher period prevalence of HPV infection over a 3-year follow-up (43.8 % vs 17.4 %, <0.001), regardless of CD4 cell counts and anti-retroviral therapy. ‘High-risk’ and ‘probable high-risk’ HPVs (types 16, 18, 31, 33, 35, 45, 52, 58 and 66), among the 20 different viral genotypes identified, were predominant in HIV-positive (33.9 %) compared with HIV-negative (13.9 %) women. Among HIV-infected women, with normal cytology as well as with SIL of any grade, the most common genotypes were HPV16 followed by HPV81, -58, -72, -33 and -62. HPV16 isolates from 18 HIV-positive and eight HIV-negative women were classified into variant lineages based on sequencing analysis of E6 and E7 genes and the long control region. Whilst the HPV16 G350 European variant was prevalent in both HIV-positive (10.7 %) and -negative women (3.5 %), HPV16 African 2 variant was only detected in HIV-positive women (3.6 %), suggesting different sexual mixing behaviours. The increased prevalence of uncommon viral genotypes and HPV16 variants in HIV-positive Italian women underscores the need to target a wide range of HPV types in cervical screening of high-risk women.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83553-0
2008-06-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/6/1380.html?itemId=/content/journal/jgv/10.1099/vir.0.83553-0&mimeType=html&fmt=ahah

References

  1. Ahdieh, L., Klein, R. S., Burk, R., Cu-Uvin, S., Schuman, P., Duerr, A., Safaeian, M., Astemborski, J., Daniel, R. & Shah, K. ( 2001; ). Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184, 682–690.[CrossRef]
    [Google Scholar]
  2. Bernard, H. U., Calleja-Macias, I. E. & Dunn, S. T. ( 2006; ). Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118, 1071–1076.[CrossRef]
    [Google Scholar]
  3. Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. ( 1995; ). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87, 796–802.[CrossRef]
    [Google Scholar]
  4. Buonaguro, F. M., Tornesello, M. L., Buonaguro, L., Del Gaudio, E., Beth-Giraldo, E. & Giraldo, G. ( 1994; ). Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions. In Advanced Technologies in Research, Diagnosis and Treatment of AIDS and in Oncology, 1st edn, pp. 102–109. Edited by G. Giraldo, M. Salvatore, L. Chieco-Bianchi & E. Beth-Giraldo. Basel: Karger.
  5. Cappiello, G., Garbuglia, A. R., Salvi, R., Rezza, G., Giuliani, M., Pezzotti, P., Suligoi, B., Branca, M., Migliore, G. & other authors ( 1997; ). HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer 72, 982–986.[CrossRef]
    [Google Scholar]
  6. Cardillo, M., Hagan, R., Abadi, J. & Abadi, M. A. ( 2001; ). CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cancer 93, 111–114.[CrossRef]
    [Google Scholar]
  7. Castellsagué, X. & Muñoz, N. ( 2003; ). Chapter 3: cofactors in human papillomavirus carcinogenesis – role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31, 20–28.
    [Google Scholar]
  8. Cerqueira, D. M., de Moraes, S., Camara, G. N., Amaral, F. A., Oyama, C. N., dos Santos, M. Q. & Martins, C. R. ( 2007; ). High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 152, 75–83.[CrossRef]
    [Google Scholar]
  9. Chaturvedi, A. K., Brinkman, J. A., Gaffga, A. M., Dumestre, J., Clark, R. A., Braly, P. S., Dunlap, K., Kissinger, P. J. & Hagensee, M. E. ( 2004; ). Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 85, 1237–1241.[CrossRef]
    [Google Scholar]
  10. Clifford, G. M., Goncalves, M. A. & Franceschi, S. ( 2006; ). Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 20, 2337–2344.[CrossRef]
    [Google Scholar]
  11. Heard, I., Potard, V., Foulot, H., Chapron, C., Costagliola, D. & Kazatchkine, M. D. ( 2005; ). High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women. J Acquir Immune Defic Syndr 39, 412–418.[CrossRef]
    [Google Scholar]
  12. Hiller, T., Poppelreuther, S., Stubenrauch, F. & Iftner, T. ( 2006; ). Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol Biomarkers Prev 15, 1262–1267.[CrossRef]
    [Google Scholar]
  13. IARC ( 1995; ). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 64, Human Papillomaviruses. International Agency for Research on Cancer.
  14. Levi, J. E., Kleter, B., Quint, W. G., Fink, M. C., Canto, C. L., Matsubara, R., Linhares, I., Segurado, A., Vanderborght, B. & other authors ( 2002; ). High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 40, 3341–3345.[CrossRef]
    [Google Scholar]
  15. Luque, A. E., Jabeen, M., Messing, S., Lane, C. A., Demeter, L. M., Rose, R. C. & Reichman, R. C. ( 2006; ). Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 194, 428–434.[CrossRef]
    [Google Scholar]
  16. Massad, L. S., Riester, K. A., Anastos, K. M., Fruchter, R. G., Palefsky, J. M., Burk, R. D., Burns, D., Greenblatt, R. M., Muderspach, L. I. & Miotti, P. ( 1999; ). Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 21, 33–41.[CrossRef]
    [Google Scholar]
  17. Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. & Meijer, C. J. ( 2003; ). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518–527.[CrossRef]
    [Google Scholar]
  18. Muñoz, N., Castellsagué, X., de Gonzalez, A. B. & Gissmann, L. ( 2006; ). Chapter 1: HPV in the etiology of human cancer. Vaccine 24 (Suppl. 3), S1–S10.
    [Google Scholar]
  19. Poljak, M., Marin, I. J., Seme, K. & Vince, A. ( 2002; ). Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 (Suppl. 3), S89–S97.[CrossRef]
    [Google Scholar]
  20. Rezza, G., Giuliani, M., Branca, M., Benedetto, A., Migliore, G., Garbuglia, A. R., D'Ubaldo, C., Pezzotti, P., Cappiello, G. & other authors ( 1997; ). Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol 13, 937–943.[CrossRef]
    [Google Scholar]
  21. Rezza, G., Giuliani, M., Serraino, D., Branca, M., Benedetto, A., Garbuglia, A., Ippolito, G. & Franceschi, S. ( 1998; ). Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group. Epidemiol Infect 121, 173–177.[CrossRef]
    [Google Scholar]
  22. Rowhani-Rahbar, A., Hawes, S. E., Sow, P. S., Toure, P., Feng, Q., Dem, A., Dembele, B., Critchlow, C. W., N'Doye, I. & Kiviat, N. B. ( 2007; ). The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 196, 887–894.[CrossRef]
    [Google Scholar]
  23. Schlecht, N. F., Burk, R. D., Palefsky, J. M., Minkoff, H., Xue, X., Massad, L. S., Bacon, M., Levine, A. M., Anastos, K. & other authors ( 2005; ). Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol 86, 2709–2720.[CrossRef]
    [Google Scholar]
  24. Sherman, M. E., Carreon, J. D. & Schiffman, M. ( 2006; ). Performance of cytology and human papillomavirus testing in relation to the menstrual cycle. Br J Cancer 94, 1690–1696.
    [Google Scholar]
  25. Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R. & Clifford, G. M. ( 2007; ). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121, 621–632.[CrossRef]
    [Google Scholar]
  26. Strickler, H. D., Palefsky, J. M., Shah, K. V., Anastos, K., Klein, R. S., Minkoff, H., Duerr, A., Massad, L. S., Celentano, D. D. & other authors ( 2003; ). Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95, 1062–1071.[CrossRef]
    [Google Scholar]
  27. Sun, X. W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J. & Wright, T. C., Jr ( 1997; ). Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337, 1343–1349.[CrossRef]
    [Google Scholar]
  28. Tornesello, M. L., Buonaguro, F. M., Beth-Giraldo, E. & Giraldo, G. ( 1993; ). Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 36, 57–64.
    [Google Scholar]
  29. Tornesello, M. L., Buonaguro, F. M., Meglio, A., Buonaguro, L., Beth-Giraldo, E. & Giraldo, G. ( 1997; ). Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78, 2199–2208.
    [Google Scholar]
  30. Tornesello, M. L., Buonaguro, F. M., Buonaguro, L., Salatiello, I., Beth-Giraldo, E. & Giraldo, G. ( 2000; ). Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 81, 2969–2982.
    [Google Scholar]
  31. Tornesello, M. L., Duraturo, M. L., Salatiello, I., Buonaguro, L., Losito, S., Botti, G., Stellato, G., Greggi, S., Piccoli, R. & other authors ( 2004; ). Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74, 117–126.[CrossRef]
    [Google Scholar]
  32. Tornesello, M. L., Duraturo, M. L., Botti, G., Greggi, S., Piccoli, R., De Palo, G., Montella, M., Buonaguro, L. & Buonaguro, F. M. ( 2006; ). Prevalence of alpha-papillomavirus genotypes in cervical intraepithelial neoplasia and cervical cancer in the Italian population. J Med Virol 78, 1663–1672.[CrossRef]
    [Google Scholar]
  33. Tornesello, M. L., Duraturo, M. L., Buonaguro, L., Vallefuoco, G., Piccoli, R., Palmieri, S. & Buonaguro, F. M. ( 2007; ). Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2, 1 [CrossRef]
    [Google Scholar]
  34. Tweddel, G., Heller, P., Cunnane, M., Multhaupt, H. & Roth, K. ( 1994; ). The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol 52, 161–164.[CrossRef]
    [Google Scholar]
  35. Vernon, S. D., Hart, C. E., Reeves, W. C. & Icenogle, J. P. ( 1993; ). The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 27, 133–145.[CrossRef]
    [Google Scholar]
  36. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J. & Muñoz, N. ( 1999; ). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12–19.[CrossRef]
    [Google Scholar]
  37. Wang, S. S. & Hildesheim, A. ( 2003; ). Chapter 5: viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 31, 35–40.
    [Google Scholar]
  38. Winship, P. R. ( 1989; ). An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res 17, 1266 [CrossRef]
    [Google Scholar]
  39. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K. & Kiviat, N. B. ( 1997; ). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89, 796–802.[CrossRef]
    [Google Scholar]
  40. Xi, L. F., Carter, J. J., Galloway, D. A., Kuypers, J., Hughes, J. P., Lee, S. K., Adam, D. E., Kiviat, N. B. & Koutsky, L. A. ( 2002; ). Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11, 343–351.
    [Google Scholar]
  41. Xi, L. F., Kiviat, N. B., Hildesheim, A., Galloway, D. A., Wheeler, C. M., Ho, J. & Koutsky, L. A. ( 2006; ). Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst 98, 1045–1052.[CrossRef]
    [Google Scholar]
  42. Xi, L. F., Koutsky, L. A., Hildesheim, A., Galloway, D. A., Wheeler, C. M., Winer, R. L., Ho, J. & Kiviat, N. B. ( 2007; ). Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 16, 4–10.[CrossRef]
    [Google Scholar]
  43. Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Muñoz, N., Bosch, F. X. & Wheeler, C. M. ( 1997; ). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71, 2463–2472.
    [Google Scholar]
  44. zur Hausen, H. ( 1987; ). Papillomaviruses in human cancer. Appl Pathol 5, 19–24.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83553-0
Loading
/content/journal/jgv/10.1099/vir.0.83553-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error